MIDI is now officially an international entity.

The medical device consulting firm has expanded into Toronto, Canada. “MIDI’s expansion into Toronto represents a strategic decision to immerse ourselves in one of the most innovative and supportive medtech environments in the world. By leveraging Toronto’s rich resources, collaborative ecosystem, and government incentives, we are well-positioned to elevate our services, support the next generation of medical device innovations, and drive growth for our clients and partners,” MIDI CEO Christopher Montalbano said.

Smithtown, N.Y.-based MIDI was driven to establish a presence in Toronto by the city’s strong medtech ecosystem, healthcare infrastructure, and thriving startup community, according to the company. The region offers an ideal environment for medical device innovation due to its infrastructure of hospitals, research institutions, and technical universities. Additionally, the Canadian government’s Scientific Research and Experimental Development (SR&ED) program offers tax credits that reduce R&D costs, aligning with MIDI’s innovation-driven mission.

Toronto’s medtech ecosystem is among the largest and most diverse in North America, providing ample collaboration opportunities, MIDI claims. The firm’s Toronto division will enhance its ability to work closely with industry leaders, established companies, and startups, further supporting its clients’ product development and commercialization needs.

Access to top-tier technical universities in Toronto gives MIDI a steady pipeline of talent, including engineers, scientists, and researchers. This proximity fosters partnerships and collaborative research opportunities, allowing MIDI to bring fresh perspectives and innovative solutions to its clients.

MIDI worked closely with the region’s economic development agency, Toronto Global, to leverage the local resources and incentive opportunities.

“Congratulations to MIDI on this expansion to Canada’s technology and healthcare hub. MIDI’s presence in our region will offer our strong ecosystem of diverse companies to access an experienced player in medical device development,” Toronto Global CEO Stephen Lund said. “We look forward to seeing the profound impact MIDI will have on not only our economy but the future of healthcare in the Toronto region.”

Known for its Development DNA service, MIDI offers a comprehensive medical device development consulting service that ensures competitive differentiation for its clients while maintaining industry standards. MIDI’s success stems from core values like insightful research, user-centered design, advanced engineering, and scalable commercialization services. The company provides support at every stage of the product lifecycle.

MIDI is a full-service U.S. Food and Drug Administration- and ISO (International Organization for Standardization)-compliant medical device development consulting firm with 50 years of experience serving clients in the medical, life sciences, and home healthcare markets. MIDI’s teams of research, design, and engineering professionals offer a combination of talent, experience, and achievement in developing Class I, II, and III products.